Opening the filing
‹ News
Nutra Pharma Corp
8-K
Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.01. Changes in Control of Registrant.
On August 21, 2026, Rik Deitsch transferred twelve million (12,000,000) shares of the Company’s Series B Preferred Stock to Pure Raw Supplies, LLC as a gift and for no consideration.
Pursuant to the Certificate of Designation of the Series B Preferred Stock, the shares possess supermajority voting rights that provide the holder with voting power sufficient to control the outcome of substantially all matters submitted to the Company’s stockholders for approval.
As a result of the transfer of the Series B Preferred Stock, a change in control of the Company occurred on August 21, 2026, and Pure Raw Supplies, LLC became the controlling stockholder of the Company.